Overview
- 94 inspections across 93 sites are on record.
- 85 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-10-28.
At a glance
Inspections
94
Sites
93
Observations
85
Career since
Mar 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| DAPIN GmbH | 28 Oct 2015 | Human Drugs | |
| BODE Chemie GmbH | 23 Oct 2015 | Human Drugs | On file |
| Rottendorf Pharma Gmbh | 16 Oct 2015 | Human Drugs | On file |
| Marksans Pharma Limited | 3 Sep 2015 | Human Drugs | |
| Encube Ethicals Private Limited | 27 Aug 2015 | Human Drugs |
Sites inspected
DAPIN GmbHHalle (Westf.), Germany1 insp.
BODE Chemie GmbHHamburg, Germany1 insp.
Rottendorf Pharma GmbhEnnigerloh, Germany1 insp.
Marksans Pharma LimitedVerna, India1 insp.
Encube Ethicals Private LimitedPonda, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Parul M Patel3 shared
Temar Q Williams3 shared
Ralph H Vocque2 shared
Dorothy W Lee1 shared
Mural B Gavini1 shared
Full investigator report
Get the verbatim findings behind James C Maclaughlin's 85 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site